Skip to content
Advertisement

The facade of Moderna, Inc. headquarters is seen, Tuesday, Dec. 15, 2020, in Cambridge, Mass. The Food and Drug Administration said that a second potential COVID-19 vaccine, developed by Moderna, appears safe and highly effective, bringing it to the cusp of U.S. authorization.  A panel of outside experts is expected to vote to recommend the formula on Thursday, with the FDA's green light coming soon thereafter.  (AP Photo/Elise Amendola)

The facade of Moderna, Inc. headquarters is seen, Tuesday, Dec. 15, 2020, in Cambridge, Mass. The Food and Drug Administration said that a second potential COVID-19 vaccine, developed by Moderna, appears safe and highly effective, bringing it to the cusp of U.S. authorization. A panel of outside experts is expected to vote to recommend the formula on Thursday, with the FDA's green light coming soon thereafter. (AP Photo/Elise Amendola)

Featured Photo Galleries